Guizhou Yibai Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Guizhou Yibai Pharmaceutical has a total shareholder equity of CN¥2.9B and total debt of CN¥923.6M, which brings its debt-to-equity ratio to 32.3%. Its total assets and total liabilities are CN¥4.4B and CN¥1.6B respectively.
Key information
32.3%
Debt to equity ratio
CN¥923.58m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥760.22m |
| Equity | CN¥2.86b |
| Total liabilities | CN¥1.55b |
| Total assets | CN¥4.41b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 600594's short term assets (CN¥1.9B) exceed its short term liabilities (CN¥1.1B).
Long Term Liabilities: 600594's short term assets (CN¥1.9B) exceed its long term liabilities (CN¥483.6M).
Debt to Equity History and Analysis
Debt Level: 600594's net debt to equity ratio (5.7%) is considered satisfactory.
Reducing Debt: 600594's debt to equity ratio has reduced from 32.8% to 32.3% over the past 5 years.
Debt Coverage: 600594's debt is well covered by operating cash flow (41%).
Interest Coverage: Insufficient data to determine if 600594's interest payments on its debt are well covered by EBIT.